A lot of ink has flowed describing the tough times that big pharma companies are experiencing as each, lemming-like, tumbles off the patent cliff.
BOSTON – The 2012 BIO International Convention may have fallen a tad short of its nadir in 2007, when BIO attendance topped more than 20,000 people from 49 U.S. states, Washington D.C., Puerto Rico and more than 60 countries.
BioWorld Perspectives is the official blog for news, analysis, debates, commentary and camaraderie related to the development of biotechnology drugs.
Join the Conversation